Home › Sakit ni Alzheimer › Arizona › Phoenix

Pag-aaral pangklinika para sa Sakit ni Alzheimer sa Phoenix, AZ

Isang pag-aaral para sa Sakit ni Alzheimer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Phoenix. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Nagre-recruitPhase 2

Clinical Site, Phoenix

Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06887192

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Nagre-recruitPhase 3

Banner Alzheimer's Institute, Phoenix

Edad 55 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06585787

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

Nagre-recruitPhase 2

Banner Alzheimer's Institute, Phoenix
Barrow Neurological Institute, Phoenix

Edad 55 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06847321

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Nagre-recruitPhase 3

Banner Alzheimer?s Institute, Phoenix

Edad 50 hanggang 90 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07177352

A Study of AMDX-2011P in Participants With Alzheimer's Disease

Nagre-recruitPhase 2

Associated Retina Consultants, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT06514001

Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Arizona State University, Phoenix

Edad 45 hanggang 65 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05980052

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Nagre-recruitPhase 3

Banner Alzheimer's Institute, Phoenix

Edad 55 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Nagre-recruitPhase 2

Banner Alzheimers Institute, Phoenix

Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT07094516

[18F]PI-2620 Phase 3 Histopathological Study

Nagre-recruitPhase 3

Barrow Neurological Institute, Phoenix

Edad 50 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05641688

Trial-Ready Cohort-Down Syndrome (TRC-DS)

Nagre-recruitObservasyonal na pag-aaral

Barrow Neurological Institute, Phoenix

Edad 25 hanggang 55 · Lahat ng kasarian · Na-update May 18, 2026 · NCT04165109

A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Arizona State University, Phoenix

Edad 65 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT05877196

Early-Stage Partner in Care Living Alone Plus

Nagre-recruit

Arizona State University, Phoenix

Edad 60 pataas · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT06962111

Repurposing Siponimod for Alzheimer's Disease

Nagre-recruitPhase 2

St. Joseph's Hospital and Medical Center, Phoenix

Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Mar 4, 2026 · NCT06639282

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Banner Alzheimer's Institute, Phoenix

Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT02022943

PROMIS and Mobility Evaluation in Sarcoma Patients

Nagre-recruitObservasyonal na pag-aaral

Mayo Clinic, Phoenix

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2025 · NCT07227961

Pag-aaral para sa Sakit ni Alzheimer sa ibang lungsod

Iba pang pag-aaral sa Phoenix

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.